Skip to main content

Table 2 mRNA expression levels in nontransformed and malignant breast cells a

From: Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy

Cell line CDK11 b CK2α CK2α
MCF-10A 1.53 ± 0.04 2.90 ± 0.35 5.19 ± 0.36
MCF-12A 1.38 ± 0.07 1.91 ± 0.17 1.05 ± 0.03
MDA-MB-231 0.96 ± 0.10 2.91 ± 0.48 0.40 ± 0.004
MDA-MB-468 0.87 ± 0.11 3.18 ± 0.06 2.91 ± 0.39
SUM-149 0.31 ± 0.001 0.66 ± 0.08 1.84 ± 0.01
  1. Data presented as mean ± standard error. amRNA expression normalized to HPRT-1. bBoth human genes (CDC2L1 and CDC2L2) recognized by PCR probes.